← Back
Data updated: Mar 29, 2026
ORBICULAR
Metabolic
Generics
ORBICULAR is a generic drug manufacturer focused on Metabolic.
2026
Since
1
Drugs
-
Trials
8
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
LIRAGLUTIDE 2026-02-24
LIRAGLUTIDE 2026-02-24
LIRAGLUTIDE 2026-01-14
LIRAGLUTIDE 2025-10-15
Labeling
LIRAGLUTIDE 2025-08-27
LIRAGLUTIDE 2025-07-22
LIRAGLUTIDE 2025-04-02
LIRAGLUTIDE 2024-12-23
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Metabolic 100%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2026-01-14
- Latest
- 2026-02-24
- Applications
- 3